Division of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Division of Genetics, Seattle Children's Hospital, Seattle, WA, USA.
Pediatr Cardiol. 2021 Mar;42(3):510-516. doi: 10.1007/s00246-020-02508-7. Epub 2021 Jan 4.
The prevalence of obstructive sleep apnea (OSA) is increased in children and adults with Marfan syndrome (MFS) compared to the general population and has been shown to be associated with rapid aortic root dilation and dissection in adults. Early diagnosis and treatment of OSA may decrease long-term cardiac morbidity. We therefore studied the utility of noninvasive OSA screening tools in children with MFS. We hypothesized that youth with MFS would have higher OSA screening scores than the general pediatric population. Subjects with confirmed MFS were recruited from a single pediatric center. Data collected included cardiac history, retrospective polysomnogram (PSG) data, and prospectively collected Pediatric Sleep Questionnaire (SRBD-PSQ) and Epworth Sleepiness Scale (ESS-CHAD) scores. Fifty-one individuals aged 2-21 years old were identified. Nineteen subjects completed the surveys, 53% female, median age 16 years. Of those that completed the survey, mean SRBD-PSQ score was 0.24 ± 0.21 and mean ESS-CHAD was 6.4 ± 3.7. Comparatively, published normative data for pediatric control subjects were 0.24 ± 0.21 for SRBD-PSQ and 5.4 ± 3.7 for ESS-CHAD. In conclusions, youth with MFS had similar OSA screening scores compared to published pediatric controls. Given these findings and high prevalence of OSA in MFS youth, standard questionnaires may not be an appropriate tool for identifying children at risk for OSA in this population. In the absence of evidence-based guidelines, physicians caring for children with MFS should consider referral for PSG, even in the absence of classic symptoms.
阻塞性睡眠呼吸暂停(OSA)在马凡综合征(MFS)儿童和成人中的患病率高于普通人群,并且已被证明与成人主动脉根部快速扩张和夹层有关。早期诊断和治疗 OSA 可能会降低长期心脏发病率。因此,我们研究了非侵入性 OSA 筛查工具在 MFS 儿童中的应用。我们假设 MFS 青少年的 OSA 筛查评分会高于普通儿科人群。从一家儿科中心招募了确诊为 MFS 的患者。收集的数据包括心脏病史、回顾性多导睡眠图(PSG)数据以及前瞻性收集的儿科睡眠问卷(SRBD-PSQ)和嗜睡量表(ESS-CHAD)评分。共确定了 51 名年龄在 2-21 岁的个体。19 名受试者完成了调查,女性占 53%,中位年龄为 16 岁。在完成调查的受试者中,平均 SRBD-PSQ 评分为 0.24±0.21,平均 ESS-CHAD 为 6.4±3.7。相比之下,儿科对照受试者的公布正常值为 0.24±0.21 的 SRBD-PSQ 和 5.4±3.7 的 ESS-CHAD。总之,MFS 青少年的 OSA 筛查评分与公布的儿科对照相似。鉴于这些发现以及 MFS 青少年中 OSA 的高患病率,标准问卷可能不是识别该人群中 OSA 风险儿童的合适工具。在缺乏循证指南的情况下,治疗 MFS 儿童的医生应考虑进行 PSG 检查,即使没有典型症状。